Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / PHARMACEUTICALS
-
Total 13F shares
-
1,016,761
-
Share change
-
-82,595
-
Total reported value
-
$72,629,765
-
Price per share
-
$71.39
-
Number of holders
-
84
-
Value change
-
-$5,493,688
-
Number of buys
-
25
-
Number of sells
-
33
Institutional Holders of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) as of Q4 2020
As of 31 Dec 2020,
INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) was held by
84 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,016,761 shares.
The largest 10 holders included
Peak Asset Management, LLC, Advocacy Wealth Management Services, LLC, Brinker Capital Investments, LLC, BANK OF AMERICA CORP /DE/, LPL Financial LLC, GOLDMAN SACHS GROUP INC, UBS Group AG, ENVESTNET ASSET MANAGEMENT INC, Federation des caisses Desjardins du Quebec, and MORGAN STANLEY.
This page lists
85
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.